
Infected bone lesions are characterized by concurrent bacterial infection, persistent inflammatory infiltration, peripheral nerve damage, and impaired osteogenesis. However, most biomaterials address only antibacterial, anti-inflammatory, or osteogenic functions while overlooking nerve-bone crosstalk during tissue repair. Here, we engineered QOMB, an injectable photothermal hydrogel responsive to near-infrared (NIR) irradiation, by embedding manganese-doped bioactive glass nanoparticles (Mn-BGN) within a dynamically crosslinked network of gallic acid-grafted quaternized chitosan (QCSG) and oxidized sodium alginate (OSA). QOMB exerts synergistic photothermal antibacterial effects and promotes anti-inflammatory M2 macrophage polarization within inflammatory microenvironments. More importantly, ions released from Mn-BGN stimulate Schwann cells (SCs) to secrete abundant neurotrophic factors, thereby establishing a pro-regenerative paracrine niche that promotes osteogenic differentiation. Transcriptomic profiling and molecular validation demonstrated that stimulation with Mn-BGN-derived ionic cues activates PI3K/AKT signaling and enhances neurotrophic factor secretion by SCs. In a rat model of infected femoral condylar defects, QOMB administration combined with sequential NIR irradiation markedly suppressed local bacterial colonization, attenuated chronic inflammation, enhanced neurotrophic signaling, and accelerated de novo bone formation. These results support a material-Schwann cell-bone regulatory pathway that coordinates staged infection control and immune reprogramming with neuro-osteogenic repair.
Organoid computing leverages functional neural networks of lab-grown neural organoids to recapitulate key aspects of human brain information processing, holding promising potential in brain-inspired computing, brain-computer interfaces, neuroscience, and medicine. However, its broad application remains constrained due to technical limitations including biological variability, interface instability, stochastic performance, and limited reproducibility. Here, we present a benchmarking framework that systematically quantifies the key performance determinants of organoid computing. We operationally define ‘benchmark-ready’ organoid substrates using optional criteria encompassing viability, cellular identity, structural integrity, functional maturation, and baseline networks, supported by multimodal phenotyping. We further establish qualification metrics for organoid-machine interface and intrinsic neural and network function, including physical coupling, spatial coverage, temporal stability, spontaneous activity, and network-level organization. Finally, we introduce a hierarchical evaluation framework for stimulation-evoked computation combined with information encoding criteria, standardized scoring, and statistical reporting. We believe that the benchmarking framework may provide an adaptable foundation for standardized, reproducible and comparable evaluation of organoid computing technologies, thereby facilitating the broad adoption and application of organoid intelligence.
Inflammation-driven disorders (IDDs) arise from distinct initiating events, yet many persist because immune activation, oxidative and metabolic stress, regulated cell death, and tissue remodeling form self-reinforcing local niches. Copper connects these processes through its roles as a cuproenzyme cofactor, redox-active species and dynamically trafficked regulatory metal. Its therapeutic significance, however, is determined by disease stage, cell type, subcellular distribution and chemical state. Copper deficiency, excess or mislocalization may therefore be adaptive, protective or pathogenic in different contexts. This review develops a disease- and copper-state-specific framework that links copper homeostasis to therapeutic platform design. We first examine inflammation-associated remodeling of copper trafficking and compare representative copper states in autoimmune joint disease, metabolic inflammation, fibrosis, inflammation-associated cancer and infection-associated tissue repair. We then critically evaluate copper-dependent and copper-sensitive mechanisms governing inflammatory mediator availability, immune-cell programming and checkpoint regulation, regulated cell death, angiogenesis and stromal remodeling, while distinguishing direct mechanistic evidence from model-dependent inference. Building on this analysis, we compare pharmacological modulators with nanocarriers, copper-containing active materials and local copper-sequestering platforms that implement copper chelation or sequestration, controlled copper delivery or release, intracellular redistribution, and catalytic activation or nanozyme-like redox regulation. We further outline how pathological copper pools, activation cues, release kinetics, speciation, biodistribution and target engagement should be measured so that precision is demonstrated rather than inferred from material composition. This framework positions copper modulation as a context-specific complement to existing therapy and defines the mechanistic, analytical and translational evidence required for microenvironment-adaptive treatment of IDDs.
The efficacy of cancer vaccines depends on spatiotemporally coordinated innate immune priming and antigen cross-presentation, but this hierarchy remains difficult to control with existing delivery platforms. Here, we report a fluorinated diethylenetriamine-modified poly(aspartic acid) nanovaccine platform, termed DET-F, and identify DET-F30 as the optimized formulation for antigen delivery and immune activation. Perfluorooctyl side chains promote early endosomal toll-like receptor 3 (TLR3) associated innate immune signaling and dendritic cell maturation, whereas the pH-responsive polymer backbone facilitates subsequent endosomal escape and cytosolic antigen release. This chemically encoded sequence enables delayed yet enhanced antigen cross-presentation in mature dendritic cells. DET-F30/antigen nanoparticles display efficient antigen loading and cellular uptake, activate TLR3-related innate immune pathways, and elicit robust antigen-specific CD8+ T cell immunity. In multiple tumor models, DET-F30-based vaccination suppresses tumor growth and metastasis, prolongs survival, and enhances post-surgical anti-PD-1 therapy. This work establishes fluorinated poly(amino acid)s as minimalist self-adjuvant nanovaccine vectors and demonstrates that precise polymer-architecture encoding can orchestrate sequential innate immune activation and antigen processing for improved cancer immunotherapy.
Corneal trauma is a leading cause of visual impairment and blindness worldwide, yet corneal stromal repair and regeneration remain a significant challenge in ophthalmology because of its limited intrinsic repair capacity and fibrotic scar formation during healing process. Here we report an optically and biomechanically corneal tissue-matched in situ dual-crosslinkable hydrogel that enables cell-free corneal stromal remodeling. By integrating dynamic covalent crosslinking with static photocrosslinking strategy, the optimized hydrogel-based substitute achieved high optical transparency, a refractive index of approximately 1.35, and an elastic modulus of 83.8 ± 13.4 kPa, closely resembling the properties of the healthy human cornea. In a rabbit model of deep corneal defects, the optimized in situ-forming hydrogel adapted to the defect geometry, adhered stably to the wound bed, recapitulated the optical and biomechanical properties of the native cornea, and supported scarless corneal stromal remodeling. Incorporation of the antimicrobial peptide HHC36 further endowed the hydrogel with robust antibacterial activity without compromising its optical and biomechanical properties. In a rabbit model of P. aeruginosa–infected deep corneal defects, the HHC36-loaded in situ-forming hydrogel effectively mitigated clinical signs of infection and substantially promoted corneal stromal remodeling within 30 days while reducing fibrosis. Overall, this optically and biomechanically corneal tissue-matched in situ dual-crosslinkable hydrogel might be a promising substitute for corneal stromal remodeling.